FDA Inspection
National Cancer Institute, Cancer Therapy Evaluation ProgramNational Cancer Institute, Cancer Therapy Evaluation Program – FDA Inspection, Jul 17, 2014
Record Details
This FDA Inspection record concerns National Cancer Institute, Cancer Therapy Evaluation Program, with an inspection on July 17, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 17, 2014
- Product Type
- Drugs
View Company Profile
ID · 3b211a2b-f2f0-4ba6-abdf-e658b694e7ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 891981
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.56(a)Monitoring investigations
- 21 CFR 312.53(c)(1)Investigator statement (FDA 1572)
- 21 CFR 312.53(c)(4)Financial information - sufficient and accurate
- 21 CFR 312.53(a)Investigator selection
Full citation text and observation details available on the Dashboard.
Other FDA inspections of National Cancer Institute, Cancer Therapy Evaluation Program
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 10, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for National Cancer Institute, Cancer Therapy Evaluation Program
- FDA Inspection 1118260 - 2020-01-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.